Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France

Emerging Infectious Diseases

Volumn 17, Issue 1, 2011, Pages 30-37

  Legrand Abravanel, Florence ^a,b   Kamar, Nassim ^a,b   Sandres Saune, Karine ^a,b   Lhomme, Sebastien ^a,b   Mansuy, Jean Michel ^b   Muscari, Fabrice ^b   Sallusto, Federico ^b   Rostaing, Lionel ^a,b   Izopet, Jacques ^a,b  

^a INSERM   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIVER ENZYME;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRANCE; HEPATITIS E; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEROPREVALENCE; VIRUS REACTIVATION; VIRUS TRANSMISSION; ZOONOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; FRANCE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; VIRUS ACTIVATION; YOUNG ADULT;

EID: 78650978500     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1701.100527     Document Type: Article

References (39)

1. Emerson SU, Purcell RH. Hepatitis E virus. Rev Med Virol. 2003;13:145-154. DOI: 10.1002/rmv.384
2. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8:698-709. DOI: 10.1016/S1473-3099(08)70255-X
3. Meng XJ. Recent advances in hepatitis E virus. J Viral Hepat. 2010;17:153-161. DOI: 10.1111/j.1365-2893.2009.01257.x
4. Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis. 2008;47:1026-1031. DOI: 10.1086/591970
5. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002;40:117-122. DOI: 10.1128/JCM.40.1.117-122.2002
6. Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis. 2005;11:1958-1960.
7. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362:371-373. DOI: 10.1016/S0140-6736(03)14025-1
8. Yazaki Y, Mizuo H, Takahashi M, Nishizawa T, Sasaki N, Gotanda Y, et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol. 2003;84:2351-2357. DOI: 10.1099/vir.0.19242-0
9. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med. 2006;16:79-83. DOI: 10.1111/j.1365-3148.2006.00652.x
10. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis. 2007;13:648-649. DOI: 10.3201/eid1304.061387
11. Mansuy JM, Huynh A, Abravanel F, Recher C, Peron JM, Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis. 2009;48:373-374. DOI: 10.1086/595893
12. Dalton HR, Thurairajah PH, Fellows HJ, Hussaini HS, Mitchell J, Bendall R, et al. Autochthonous hepatitis E in southwest England. J Viral Hepat. 2007;14:304-309. DOI: 10.1111/j.1365-2893.2006.00800.x
13. Péron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14:298-303. DOI: 10.1111/j.1365-2893.2007.00858.x
14. Gérolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol. 2009;50:622-624. DOI: 10.1016/j.jhep.2008.12.008
15. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008;14:547-553. DOI: 10.1002/ lt.21480
16. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811-817. DOI: 10.1056/NEJMoa0706992
17. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann InternMed. 2009;150:430-431.
18. Péron JM, Mansuy JM, Recher C, Bureau C, Poirson H, Alric L, et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol. 2006;21:1223-1224. DOI: 10.1111/j.1440-1746.2006.04209.x
19. Colson P, Kaba M, Moreau J, Brouqui P. Hepatitis E in an HIV infected patient. J Clin Virol. 2009;45:269-2671. DOI: 10.1016/j.jcv.2009.06.002
20. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361:1025-1027. DOI: 10.1056/NEJMc0903778
21. le Coutre P, Meisel H, Hofmann J, Rocken C, Vuong GL, Neuburger S, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut. 2009;58:699-702. DOI: 10.1136/gut.2008.165571
22. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from south west France. J Med Virol. 2008;80:289-293. DOI: 10.1002/jmv.21056
23. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssiere L, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation. 2010;89:353-360. DOI: 10.1097/TP.0b013e3181c4096c
24. Mansuy JM, Abravanel F, Miedouge M, Mengelle C, Merviel C, Dubois M, et al. Acute hepatitis E in south-west France over a 5-year period. J Clin Virol. 2009;44:74-77. DOI: 10.1016/j.jcv.2008.09.010
25. Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol. 2004;74:419-424. DOI: 10.1002/jmv.20206
26. Legrand-Abravanel F, Mansuy JM, Dubois M, Kamar N, Peron JM, Rostaing L, et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis. 2009;15:110-114. DOI: 10.3201/eid1501.080296
27. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16:5-36. DOI: 10.1002/rmv.482
28. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009;15:1225-1228. DOI: 10.1002/lt.21819
29. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl. 2010;16:74-82. DOI: 10.1002/lt.21958
30. Buti M, Cabrera C, Jardi R, Castells L, Esteban R. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl. 2010;16:106-107; author reply 108. DOI: 10.1002/lt.21925
31. Legrand-Abravanel F, Thevenet I, Mansuy JM, Saune K, Vischi F, Peron JM, et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol. 2009;16:772-774. DOI: 10.1128/CVI.00438-08
32. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis. 2010;202:835-844. DOI: 10.1086/655899
33. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82:799-805. DOI: 10.1002/jmv.21656
34. Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology. 1998;27:857-861. DOI: 10.1002/hep.510270331
35. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, et al. Chikungunya disease in nonhuman primates involves longterm viral persistence in macrophages. J Clin Invest. 2010;120:894-906. DOI: 10.1172/JCI40104
36. Way SJ, Lidbury BA, Banyer JL. Persistent Ross River virus infectionof murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection. Virology. 2002;301:281-292. DOI: 10.1006/viro.2002.1587
37. Luo H, Chen H, Daloze P, Chang JY, St-Louis G, Wu J. Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation. 1992;53:1071-1076. DOI: 10.1097/00007890-199205000-00019
38. Rentenaar RJ, van Diepen FN, Meijer RT, Surachno S, Wilmink JM, Schellekens PT, et al. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int. 2002;62:319-328. DOI: 10.1046/j.1523-1755.2002.00425.x
39. Arthurs SK, Eid AJ, Pedersen RA, Dierkhising RA, Kremers WK, Patel R, et al. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl. 2007;13:1703-1709. DOI: 10.1002/lt.21280